IFNA1 and Miyoshi myopathy: To do so, we characterized and compared the protein content of MM CSCs released exosomes, of control CSCs versus IFN-α treated CSCs, by NanoSight, TEM, SEM Western blot and LC-HRMS-based metabolomic analysis.